Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis)Luigi Gargiulo, Alessandra Narcisi, Fabrizio Amoruso et al.|Journal of Dermatological Treatment|2024Cited by 21
FOXP3 expression is modulated by TGF‑β1/NOTCH1 pathway in human melanomaEva Skarmoutsou, Claudio Guarneri|International Journal of Molecular Medicine|2018Cited by 17